These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 31954772)

  • 1. Methods for characterizing, applying, and teaching CRISPR-Cas systems.
    Beisel CL
    Methods; 2020 Feb; 172():1-2. PubMed ID: 31954772
    [No Abstract]   [Full Text] [Related]  

  • 2. CRISPR-Cas in the laboratory classroom.
    Trudel L; Frenette M; Moineau S
    Nat Microbiol; 2017 Feb; 2():17018. PubMed ID: 28211845
    [No Abstract]   [Full Text] [Related]  

  • 3. A decade of discovery: CRISPR functions and applications.
    Barrangou R; Horvath P
    Nat Microbiol; 2017 Jun; 2():17092. PubMed ID: 28581505
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diversity and evolution of class 2 CRISPR-Cas systems.
    Shmakov S; Smargon A; Scott D; Cox D; Pyzocha N; Yan W; Abudayyeh OO; Gootenberg JS; Makarova KS; Wolf YI; Severinov K; Zhang F; Koonin EV
    Nat Rev Microbiol; 2017 Mar; 15(3):169-182. PubMed ID: 28111461
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CRISPR-Cas experiments for schools and the public.
    Ziegler H; Nellen W
    Methods; 2020 Feb; 172():86-94. PubMed ID: 31472270
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CRISPR-Cas9: From a bacterial immune system to genome-edited human cells in clinical trials.
    Kick L; Kirchner M; Schneider S
    Bioengineered; 2017 May; 8(3):280-286. PubMed ID: 28287876
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization and applications of Type I CRISPR-Cas systems.
    Hidalgo-Cantabrana C; Barrangou R
    Biochem Soc Trans; 2020 Feb; 48(1):15-23. PubMed ID: 31922192
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rapid Control of Genome Editing in Human Cells by Chemical-Inducible CRISPR-Cas Systems.
    Liu KI; Ramli MNB; Sutrisnoh NB; Tan MH
    Methods Mol Biol; 2018; 1772():267-288. PubMed ID: 29754234
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular biology at the cutting edge: A review on CRISPR/CAS9 gene editing for undergraduates.
    Thurtle-Schmidt DM; Lo TW
    Biochem Mol Biol Educ; 2018 Mar; 46(2):195-205. PubMed ID: 29381252
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeted Gene Manipulation in Plants Using the CRISPR/Cas Technology.
    Zhang D; Li Z; Li JF
    J Genet Genomics; 2016 May; 43(5):251-62. PubMed ID: 27165865
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sensitizing pathogens to antibiotics using the CRISPR-Cas system.
    Goren M; Yosef I; Qimron U
    Drug Resist Updat; 2017 Jan; 30():1-6. PubMed ID: 28363331
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CRISPR/Cas9: Nature's gift to prokaryotes and an auspicious tool in genome editing.
    Khanzadi MN; Khan AA
    J Basic Microbiol; 2020 Feb; 60(2):91-102. PubMed ID: 31693214
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Methods of Evaluating the Efficiency of CRISPR/Cas Genome Editing].
    Lomov NA; Viushkov VS; Petrenko AP; Syrkina MS; Rubtsov MA
    Mol Biol (Mosk); 2019; 53(6):982-997. PubMed ID: 31876277
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Biology and Application Areas of CRISPR Technologies.
    Adli M
    J Mol Biol; 2019 Jan; 431(1):1-2. PubMed ID: 30447221
    [No Abstract]   [Full Text] [Related]  

  • 15. Phage-Encoded Anti-CRISPR Defenses.
    Stanley SY; Maxwell KL
    Annu Rev Genet; 2018 Nov; 52():445-464. PubMed ID: 30208287
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Guest editorial: CRISPRcas9: CRISPR-Cas systems: at the cutting edge of microbiology.
    Barrangou R; Bikard D
    Curr Opin Microbiol; 2017 Jun; 37():vii-viii. PubMed ID: 29096913
    [No Abstract]   [Full Text] [Related]  

  • 17. CRISPR-Cas System: History and Prospects as a Genome Editing Tool in Microorganisms.
    Javed MR; Sadaf M; Ahmed T; Jamil A; Nawaz M; Abbas H; Ijaz A
    Curr Microbiol; 2018 Dec; 75(12):1675-1683. PubMed ID: 30078067
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Bacterial genome editing using the CRISPR/Cas12a system].
    Castagné P; Guingand A; Moderc A; Monard S
    Med Sci (Paris); 2018 May; 34(5):399-400. PubMed ID: 29900839
    [No Abstract]   [Full Text] [Related]  

  • 19. [The CRISPR/Cas system: a genome editing tool to develop animal models of viral infections].
    Castino G; Guillemet M; Joly A; Vignon A
    Med Sci (Paris); 2018 May; 34(5):403-405. PubMed ID: 29900841
    [No Abstract]   [Full Text] [Related]  

  • 20. Application of CRISPR/Cas-mediated base editing for directed protein evolution in plants.
    Capdeville N; Schindele P; Puchta H
    Sci China Life Sci; 2020 Apr; 63(4):613-616. PubMed ID: 32146695
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.